Selected biomarkers related to COVID-19 in the two study groups (n = 139); mean (days) ± standard deviation.
COVID-19 PNEUMONIA
*Statistically significant (P<0.05, Mann Whitney statistic) change from baseline within the study group for all variables except Pro-calcitonin**NS Not statistically significant (P> = 0.05)Note, Abbreviation: AYUSH plus: AYUSH 64 + Standard of Care (SOC); n = number of participants; See text for detailEight participants (18.6%) in the AYUSH plus and 13 participants (30.2%) in the SOC group showed radiological features of definite COVID-19 pneumonia at the time of randomization baseline (See Table S5.6 in In comparison to SOC, AYUSH Plus showed significant improvement in several domains (physical health, psychological health, social relationship, and environmental well-being) in the WHO QOL BREF and the total HR-BHF score at the time of clinical recovery and during follow-up (